Log in or Sign up for Free to view tailored content for your specialty!
Schizophrenia News
Link between cannabis use disorder, schizophrenia strongest in young men
The association between cannabis use disorder and schizophrenia was stronger in men compared with women, particularly among people aged 16 to 20 years, according to a study published in Psychological Medicine.
Perceived impact of tardive dyskinesia differs among patients, health care professionals
CHICAGO — Patients with tardive dyskinesia reported greater impact on quality of life than health care providers, according to a poster at the International Association of Parkinsonism and Related Disorders World Congress.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: Investigational digital therapeutic may help improve schizophrenia
Click Therapeutics announced it has enrolled the first patient in a clinical trial of an investigational prescription digital therapeutic to support standard antipsychotic treatment of schizophrenia, according to a company press release.
First patient dosed in risperidone clinical trial for schizophrenia, bipolar disorder
A biopharmaceutical company announced it has dosed the first patient in a clinical trial of a long-acting oral treatment for schizophrenia, schizoaffective disorder and bipolar I disorder, according to a company press release.
Higher rate of hip fractures found for patients with schizophrenia
Patients with schizophrenia experienced earlier onset and higher rates of hip fractures compared with the general population, according to study results published in JAMA Network Open.
Mental illness in young adults tied to heart attack, stroke risk
Young adults with any mental disorder are at 58% greater risk for MI and 42% greater risk for stroke compared with those without a mental illness, data from a population-based study show.
FDA approves long-acting injection for schizophrenia
The FDA approved a long-acting formulation for the treatment of schizophrenia, according to a press release from the manufacturers.
FDA approves long-acting injectable for schizophrenia, bipolar I disorder
The FDA has approved a new drug application for aripiprazole, an extended-release injection for the treatment of schizophrenia and bipolar disorder, according to a press release from the manufacturers.
Schizophrenic individuals have increased risk for sudden cardiac death
Young people with schizophrenia had elevated risk for sudden cardiac death, and biopsychosocial factors related to social isolation impacted the cardiac risk factor burden in individuals with schizophrenia, researchers reported.
Schizophrenia drug demonstrates efficacy, tolerability in phase 3 trial
KarXT was efficacious and safe in and well-tolerated by people with schizophrenia, according to a press release from its manufacturer.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read